AstraZeneca and its partner Oxford University said on Monday its vaccine is highly effective in protecting against coronavirus, becoming the third drugmaker to release positive data in the scientific race to curb the pandemic.The company said it will have 200 million doses of its candidate by the end of 2020, with 700 million doses ready globally by the end of the first quarter of 2021.
AstraZeneca says late-stage trials show coronavirus vaccine ‘highly effective’ The announcement comes on the heels of Pfizer and Moderna’s promising coronavirus vaccine data from their late-stage trials.Pfizer announced on Nov.
18 that it intends to file for emergency authorization with the U.S. Food and Drug Administration days after saying its final.